Bayer

SKYLA

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Bayer

Skyla HCPCS:

J7301

HCPCS Code Descriptor:

Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg

Category:

J Code

Skyla NDCs:

50419-0422-01

Primary Type:

Contraceptive/ Long Acting Reversible

Generic/Specialty Status:

Single-Source

Package Type:

Kit

Route of Administration:

Intrauterine

Skyla CPT Codes:

-58300, 58301, 81025, 76998, 76857, 76830 *More information on CPT codes can be found here https://www.kyleenahcp.com/CompassGuide_Dig_Sales_Aid_March2022_FR08_LD.pdf

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have not identified any potential errors with the NDCs mapped to this HCPCS code.

About Skyla:

SKYLA is a Contraceptive/ Long Acting Reversible drug manufactured by Bayer and administered via the Intrauterine route of administration. The J Code: J7301 is aligned to the drug SKYLA.

ACCESS PRICING AND MORE BY REGISTERING

J7301 Added Date:

January 1, 2014

J7301 Effective Date:

January 1, 2017

J7301 Termination Date:

HCPCS Active

View a Skyla billing and coding guide at the link below:
Skyla patient assistance information can be found through Bayer Patient Assistance at the URL: https://www.patientassistance.bayer.us/
SKYLA prescribing information can be found at the link below:
Information regarding SKYLA’s side effects can be found at MedlinePlus